Table 4 Follow-up characteristics of patients combined with moderate aortic regurgitation .

From: Clinical outcomes and management strategies for moderate aortic regurgitation in patients undergoing rheumatic mitral valve surgery

Characteristic

Total

(N = 287)

NT

(N = 112)

AVP

(N = 73)

AVR

(N = 102)

P value

More-than-mild mitral valve dysfunction

41 (14.3)

14 (12.6)

16 (21.9)

11 (10.8)

0.09

Mitral stenosis

    

0.48

    None or mild

280 (97.6)

108 (96.4)

71 (97.3)

101 (99.0)

 

    Moderate

5 (1.7)

3 (2.7)

2 (2.7)

0 (0)

 

    Severe

2 (0.7)

1 (0.9)

0 (0)

1 (1.0)

 

Mitral regurgitation

    

0.09

    None or mild

251 (87.5)

101 (90.2)

58 (79.5)

92 (90.2)

 

    Moderate

30 (10.5)

8 (7.1)

12 (16.4)

10 (9.8)

 

    Severe

6 (2.1)

3 (2.7)

3 (4.1)

0 (0)

 

More-than-mild aortic valve dysfunction

63 (22.0)

37 (33.0)

22 (30.1)

4 (3.9)

< 0.001†‡

Aortic stenosis

    

0.29

    None or mild

284 (99.0)

110 (98.2)

73 (100)

101 (99.0)

 

    Moderate

2 (0.7)

2 (1.8)

0 (0)

0 (0)

 

    Severe

1 (0.3)

0 (0)

0 (0)

1 (1.0)

 

Aortic regurgitation

    

< 0.001†‡

    None or mild

227 (79.1)

76 (67.9)

52 (71.2)

99 (97.1)

 

    Moderate

55 (19.2)

33 (29.5)

20 (27.4)

2 (2.0)

 

    Severe

5 (1.7)

3 (2.7)

1 (1.4)

1 (1.0)

 

More-than-mild tricuspid valve dysfunction

17 (5.9)

8 (7.1)

4 (5.5)

5 (4.9)

0.77

Tricuspid regurgitation

    

0.50

    None or mild

270 (94.1)

105 (93.8)

68 (93.2)

97 (95.1)

 

    Moderate

14 (4.9)

7 (6.2)

4 (5.5)

3 (2.9)

 

    Severe

3 (1.0)

0 (0)

1 (1.4)

2 (2.0)

 
  1. Values are n (%). NT, non-surgical treatment; AVP, aortic valvuloplasty; AVR, aortic valve replacement; . Indicates a statistically significant difference between the NT and AVR groups; . Indicates a statistically significant difference between the AVP and AVR groups.